From a clinical viewpoint, our study also provides valuable insights identifying the NLRP3-IL-1β-IL-1R1 axis as potential targets for developing new drug therapies for preventing severe infection-elicited chronic inflammation and neurodegeneration. This evidence concerns the gene IL1B and infection.